Mefloquine and Artesunate Tablet

Available Composition of

Mefloquine and Artesunate Tablet
NameStrengthTherapeutic useView More
Mefloquine and Artesunate Tablet200 mg + 100 mg
Mefloquine Tablet250 mg
Artesunate and Amodiaquine Tablet100 mg + 270 mg, 50 mg + 135 mg
Artesunate, Pyrimethamine and Sulphadoxine Tablet100 mg + 25 mg + 500 mg, 200 mg + 37.5 mg + 750 mg
Artesunate Tablet100 mg, 50 mg
Artesunate Injection120 mg, 60 mg

Product Description For Mefloquine and Artesunate Tablet

products details and uses

Mefloquine and Artesunate Tablet Exporter India , Manufacturer & Global Supplier

Mefloquine and Artesunate Tablet is a highly effective antimalarial combination used for the treatment of uncomplicated malaria caused by Plasmodium falciparum and other resistant strains of the malaria parasite. This dual formulation provides rapid action through Artesunate and sustained therapeutic coverage through Mefloquine, making it a preferred choice in malaria-endemic regions. As a trusted Mefloquine and Artesunate Tablet Exporter India, we are committed to supplying premium quality formulations that meet international standards of safety, efficacy, and affordability.

Uses of Mefloquine and Artesunate Tablet

  • Treatment of Malaria: Highly effective against chloroquine-resistant Plasmodium falciparum infections.

  • Rapid Relief: Artesunate ensures fast reduction of symptoms such as fever and chills.

  • Prevention of Recurrence: Mefloquine sustains therapeutic activity to reduce relapse chances.

  • Combination Therapy: Recommended by WHO as part of artemisinin-based combination therapies (ACTs).

As a reliable Mefloquine and Artesunate Tablet Exporter India, we ensure our products reach hospitals, NGOs, and healthcare providers across malaria-prone regions in Asia, Africa, and South America.

Precautions

Patients taking Mefloquine and Artesunate Tablet should follow medical guidance strictly. Important precautions include:

  • Should not be taken by individuals with a history of psychiatric disorders, seizures, or cardiac issues.

  • Pregnant women should consult healthcare providers before use.

  • Dosage should never be altered without medical supervision.

  • Patients should inform doctors about any ongoing medications to avoid drug interactions.

  • Not suitable for long-term prophylaxis; primarily intended for therapeutic use.

Being a responsible Mefloquine and Artesunate Tablet Exporter India, we provide detailed product leaflets and labeling to promote safe and effective use worldwide.

Side Effects

Like any medication, Mefloquine and Artesunate Tablet may cause side effects, although not everyone experiences them. Common side effects include:

  • Nausea, vomiting, or diarrhea

  • Dizziness or mild headache

  • Abdominal pain

  • Temporary sleep disturbances

Rare but serious side effects may include mood changes, anxiety, irregular heartbeat, or seizures. Patients should seek immediate medical attention if severe reactions occur. As a transparent Mefloquine and Artesunate Tablet Exporter India, we ensure healthcare professionals are well informed of potential risks.

Why Choose Us as Your Trusted Partner?

  • Leading Mefloquine and Artesunate Tablet Exporter India with global recognition.

  • WHO-GMP certified manufacturing facilities ensuring uncompromised quality.

  • Strong distribution network across malaria-endemic regions.

  • Competitive pricing, making treatments affordable for patients worldwide.

  • Trusted by governments, NGOs, hospitals, and pharmaceutical distributors.

 

Global Distribution Network

With a strong logistics and compliance framework, we successfully export to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.